Cargando…

Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-acquired pneumonia (CAP) in the intensive care unit

Detalles Bibliográficos
Autores principales:	Leroy, O, Saux, P, Bédos, J, Caulin, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099817/ http://dx.doi.org/10.1186/cc2697

Ejemplares similares

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis
por: Akcali, Sinem, et al.
Publicado: (2005)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
por: Sakai, Tatsuya, et al.
Publicado: (2019)

Atomic-Scale Resolution Insights into Structural and Dynamic Differences between Ofloxacin and Levofloxacin
por: Pradhan, Bijay Laxmi, et al.
Publicado: (2023)

SMART-COP score for patients admitted with community-acquired pneumonia (CAP) to an ICU in a district general hospital: a smarter way of identifying patients with severe CAP?
por: Pachucki, M, et al.
Publicado: (2013)

Timing of admissions and outcome of pneumonia in intensive care units in the United Kingdom
por: Boralessa, H, et al.
Publicado: (2007)

Epidemiology of community-acquired bacteremia patients admitted to the intensive care unit
por: Castro, Guiomar, et al.
Publicado: (2007)

Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?
por: Khanna, A, et al.
Publicado: (2011)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
por: Endimiani, Andrea, et al.
Publicado: (2005)

Glycemic variability as a risk factor of intensive care unit-acquired weakness
por: Mörgeli, R, et al.
Publicado: (2015)

Mortality and predictors of death in patients with pneumonia admitted to the intensive care unit
por: Lee, J, et al.
Publicado: (2005)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Surveillance of ICU-acquired infections: intensive care unit characteristics, practices in prevention and surveillance methodology
por: Morales, I, et al.
Publicado: (2005)

Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products
por: Alarfaj, Nawal Ahmed, et al.
Publicado: (2021)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)

The impact of the implementation of bundle in the prevention of ventilator-associated pneumonia in intensive care units
por: Cais, DP, et al.
Publicado: (2011)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Community-acquired bacteraemia with sepsis in adults admitted to the intensive care unit: a prospective multicentre study
por: Cardoso, Teresa, et al.
Publicado: (2007)

Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis
por: Sihotang, Tiar Sondang Uli, et al.
Publicado: (2022)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Evolution ventilator associated pneumonia (VAP) in our intensive care unit, after pneumonia zero (PZ) program implementation
por: Fernández Fernández, R, et al.
Publicado: (2015)

Population pharmacokinetics of cefotaxime in intensive care patients
por: Swartling, Maria, et al.
Publicado: (2021)

Decrease ventilator-associated pneumonia by bundle care in cardiac surgery intensive care unit
por: Hung, CT, et al.
Publicado: (2015)

Risk factors for mortality and multiresistant bacteria in bloodstream infections acquired in a private hospital intensive care unit
por: Bonell Goytisolo, JM, et al.
Publicado: (2015)

Implementing national guidelines in intensive care patients with ventilator-associated, hospital-acquired, and healthcare-associated pneumonia: the IMPACT-HAP project
por: Kett, DH, et al.
Publicado: (2008)

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

Quantitative PCR for etiologic diagnosis of methicillin-resistant Staphylococcus aureus pneumonia in intensive care unit
por: Jeon, T, et al.
Publicado: (2011)

Interdiciplinares impactanto actions on prevention of ventilator-associated pneumonia in patients of trauma intensive care unit
por: Sola, A
Publicado: (2015)

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
por: Yayan, Josef, et al.
Publicado: (2015)

Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea
por: Cho, Yongil, et al.
Publicado: (2018)

Levofloxacin induced Stevens-Johnson syndrome/ toxic epidermal necrolysis overlap syndrome: case reports
por: Aversano, Maria Gloria, et al.
Publicado: (2014)

A simple program to reduce the incidence of ventilator-associated pneumonia in a Brazilian intensive care unit
por: Souza, P, et al.
Publicado: (2005)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pl0td5oks08t78q8etfk343ncu